September 8, 2014

FEDERAL TRADE COMMISSION v. ABBVIE INC et al

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. February 7, 2018

    AbbVie Filed Patent Suits To Delay Competition, Court Told

    The patent lawsuits filed by AbbVie Inc. and Besins Healthcare Inc. over generic testosterone replacement treatments were “anti-competitive weapons” used to delay competition for the brand-name drug AndroGel, an attorney for the Federal Trade Commission said Wednesday while opening the bench trial in the agency’s antitrust suit in Pennsylvania federal court.

33 other articles on this case. View all »

Parties

To view the parties, register now.